Share Options October 1st 2010

Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of diagnostic testing kits for the clinical and research markets, announces that Ian Cookson, who will become Chief Executive Officer on 1 October 2010, has been awarded the following options to subscribe for ordinary shares of 2p each in the capital of the Company (“Ordinary Shares”)

Download Announcement